Publicaciones en las que colabora con PABLO MARTÍNEZ-LAGE ÁLVAREZ (28)
2024
-
GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe
Alzheimer's Research and Therapy, Vol. 16, Núm. 1
-
Unlocking Preclinical Alzheimer’s: A Multi-Year Label-Free In Vitro Raman Spectroscopy Study Empowered by Chemometrics
International Journal of Molecular Sciences, Vol. 25, Núm. 9
2023
-
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology
Alzheimer's and Dementia, Vol. 19, Núm. 3, pp. 807-820
-
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
Genome Medicine, Vol. 15, Núm. 1
-
The CITA GO-ON dialogue system: mid-term achievements
ACM International Conference Proceeding Series
-
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits
Alzheimer's and Dementia, Vol. 19, Núm. 6, pp. 2317-2331
2022
-
Brief cognitive test as a decision tool in Primary Care settings. Population and validation study
Neurologia
-
Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
Frontiers in Aging Neuroscience, Vol. 14
-
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation
Molecular Psychiatry, Vol. 27, Núm. 4, pp. 1990-1999
2021
-
Plasma lipids are associated with white matter microstructural changes and axonal degeneration
Brain Imaging and Behavior, Vol. 15, Núm. 2, pp. 1043-1057
-
Replication study of plasma proteins relating to Alzheimer's pathology
Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1452-1464
-
Sex-specific metabolic pathways were associated with alzheimer’s disease (Ad) endophenotypes in the european medical information framework for ad multimodal biomarker discovery cohort
Biomedicines, Vol. 9, Núm. 11
-
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
Alzheimer's and Dementia, Vol. 17, Núm. 10, pp. 1628-1640
2020
-
Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults
Journal of Alzheimer's disease : JAD, Vol. 76, Núm. 2, pp. 643-656
-
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology
Journal of Alzheimer's Disease, Vol. 77, Núm. 3, pp. 1353-1368
-
Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
Translational Psychiatry, Vol. 10, Núm. 1
-
Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
Journal of Alzheimer's Disease, Vol. 74, Núm. 1, pp. 213-225
-
World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia
Alzheimer's and Dementia, Vol. 16, Núm. 7, pp. 1078-1094
2019
-
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 5, pp. 933-938
-
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
Alzheimer's and Dementia, Vol. 15, Núm. 5, pp. 644-654